Cargando…

Apathy - where do we find it and how to treat

INTRODUCTION: Although defined heterogeneously within the literature apathy is classified as a multidimensional deficit with emotional, behavioral, and cognitive domains in which there is a decrease in self-motivated/goal-directed activity. Recently conceptualized as a syndrome but lacking a univers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gomes, R., Santos, C., Descalço, N., Moutinho, F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568103/ http://dx.doi.org/10.1192/j.eurpsy.2022.2275

Ejemplares similares

Does my lifestyle explain my depression? The role of exercise, diet and smoking in the prevention of depression
por: Gomes, R., et al.
Publicado: (2022)

Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?
por: Descalço, N., et al.
Publicado: (2021)

Is apathy a true trans-diagnostic construct? preliminary findings of the european study on apathy in schizophrenia
por: Fernandez-Egea, E.
Publicado: (2021)

A closer look to apathy
por: Silva, D., et al.
Publicado: (2021)

Maternal sleep position: what do we know where do we go?
por: O’Brien, Louise M, et al.
Publicado: (2015)

Music composers and bipolar disorders: Where do we stand?
por: Giannouli, V.
Publicado: (2021)

Overview of Antifungal Drugs against Paracoccidioidomycosis: How Do We Start, Where Are We, and Where Are We Going?
por: do Carmo Silva, Lívia, et al.
Publicado: (2020)

Neuropsychiatric complications of traumatic brain injury
por: Santos, C. Fernandes, et al.
Publicado: (2021)

Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?
por: Hasenoehrl, Carina, et al.
Publicado: (2017)

Lost in Translation – What is Alexithymia
por: Morais, A.S., et al.
Publicado: (2022)

When Attention-Deficit/Hyperactivity Disorder reaches adulthood
por: Morais, A.S., et al.
Publicado: (2022)

Use of methylphenidate in alzheimer’s dementia: Effect on apathy
por: Borralho, R., et al.
Publicado: (2021)

PS154. Aripiprazole may be effective for treating apathy after cerebral infarction
por: Mukai, Keiichiro, et al.
Publicado: (2016)

Capgras syndrome. Where to find it?
por: Carrasco, I.D.L.M. Santos, et al.
Publicado: (2021)

Should we treat pyrexia? And how do we do it?
por: Doyle, James F., et al.
Publicado: (2016)

Abstract 22: How Are We Doing At Treating Arteriovenous Malformations?
por: Demsey, Daniel, et al.
Publicado: (2020)

Hebephrenic schizophrenia as a variant of frontotemporal dementia – the true dementia praecox?
por: Medeiros, A.B., et al.
Publicado: (2021)

Apathy in patients with schizophrenia: Treatment perspectives
por: Kaiser, S.
Publicado: (2021)

Abstract P19. Fat Processing Systems Abound! Where is the Evidence and How Do We Choose One?
por: Koltz, Peter F., et al.
Publicado: (2017)

Etiopathogenesis of Graves-Basedow disease; where we are and where we are going
por: Nauman, Janusz
Publicado: (2013)

ColVI myopathies: where do we stand, where do we go?
por: Allamand, Valérie, et al.
Publicado: (2011)

Nanoparticles in the environment: where do we come from, where do we go to?
por: Bundschuh, Mirco, et al.
Publicado: (2018)

Off-label use of atypical antipsychotics- Where are we?
por: Vaz, R. P., et al.
Publicado: (2023)

PAIN IN PERSONS WITH DEMENTIA AND APATHY IN NURSING HOMES
por: Liao, Yo-Jen, et al.
Publicado: (2022)

Neuropsychiatry: Where Are We And Where Do We Go From Here?
por: Sachdev, Perminder S., et al.
Publicado: (2013)

Addictive behaviors: where do we stand, and where are we going?
por: Thibaut, Florence, et al.
Publicado: (2017)

Where Do We Stand?
Publicado: (1891)

Where do you Find Interesting Biosurveillance Publications?
por: Suda, Katie J., et al.
Publicado: (2015)

Antibiotic Discovery: Where Have We Come from, Where Do We Go?
por: Ribeiro da Cunha, Bernardo, et al.
Publicado: (2019)

Epilepsy and psychosis– where are we now?
por: Pereira, I., et al.
Publicado: (2021)

Cancer in Croatia; where do we stand and how to move forward?
por: Vrdoljak, Eduard
Publicado: (2012)

A PUBLIC HEALTH APPROACH TO ALZHEIMER’S DISEASE RISK REDUCTION: WHERE WE ARE AND WHERE WE’RE HEADED
por: Omura, John, et al.
Publicado: (2022)

What is the best approach for patients with prolonged duration of untreated psychosis (DUP) - about 2 clinical cases with dup longer than 10 years
por: Gomes, R., et al.
Publicado: (2021)

PS102. Apathy in elderly depression and the antidepressant response
por: Shimano, Takahisa, et al.
Publicado: (2016)

ActiviDaily: Turning Apathy Into Action in Neurodegenerative Disease
por: Massimo, Lauren, et al.
Publicado: (2020)

A very musical psychopathology – from intrusive musical imagery, to musical obsessions and hallucinations
por: Morais, A. S., et al.
Publicado: (2023)

Translational perspectives to treat Epidermolysis bullosa—Where do we stand?
por: Prodinger, Christine, et al.
Publicado: (2020)

Psychopharmacology Today: Where are We and Where Do We Go From Here?
por: Schwartz, Thomas L.
Publicado: (2010)

Health Psychology: Where Are We And Where Do We Go From Here?
por: Kaplan, Robert M.
Publicado: (2009)

Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go?
por: Ottenhoff, Tom H. M., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_pkbcomngtvlg66gcrhpa4mttgn